These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37144240)

  • 21. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals.
    Chen H; Hou J; Jiang X; Ma S; Meng M; Wang B; Zhang M; Zhang M; Tang X; Zhang F; Wan T; Li N; Yu Y; Hu H; Yang R; He W; Wang X; Cao X
    J Immunol; 2005 Jul; 175(1):591-8. PubMed ID: 15972696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins.
    Tajuelo A; López-Siles M; Más V; Pérez-Romero P; Aguado JM; Briz V; McConnell MJ; Martín-Galiano AJ; López D
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue.
    Mahallawi WH; Aljeraisi TM
    Clin Immunol; 2021 Oct; 231():108850. PubMed ID: 34506944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein.
    Vlasova AN; Zhang X; Hasoksuz M; Nagesha HS; Haynes LM; Fang Y; Lu S; Saif LJ
    J Virol; 2007 Dec; 81(24):13365-77. PubMed ID: 17913799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development.
    Choy WY; Lin SG; Chan PK; Tam JS; Lo YM; Chu IM; Tsai SN; Zhong MQ; Fung KP; Waye MM; Tsui SK; Ng KO; Shan ZX; Yang M; Wu YL; Lin ZY; Ngai SM
    Clin Chem; 2004 Jun; 50(6):1036-42. PubMed ID: 15044316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
    Quinti I; Locatelli F; Carsetti R
    Front Immunol; 2021; 12():815404. PubMed ID: 35126372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 Spike Protein Vaccine-Induced Immune Imprinting Reduces Nucleocapsid Protein Antibody Response in SARS-CoV-2 Infection.
    Delgado JF; Vidal-Pla M; Moya MC; Espasa M; Casabella A; Seda M; Calvet J; Gratacós J; Serrano RM; Peña P
    J Immunol Res; 2022; 2022():8287087. PubMed ID: 35935586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    He J; Huang F; Zhang J; Chen Q; Zheng Z; Zhou Q; Chen D; Li J; Chen J
    J Med Virol; 2021 Apr; 93(4):2115-2131. PubMed ID: 33091154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2.
    Denninger V; Xu CK; Meisl G; Morgunov AS; Fiedler S; Ilsley A; Emmenegger M; Malik AY; Piziorska MA; Schneider MM; Devenish SRA; Kosmoliaptsis V; Aguzzi A; Fiegler H; Knowles TPJ
    ACS Infect Dis; 2022 Apr; 8(4):790-799. PubMed ID: 35352558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J; van den Brink EN; Poon LL; Marissen WE; Leung CS; Cox F; Cheung CY; Bakker AQ; Bogaards JA; van Deventer E; Preiser W; Doerr HW; Chow VT; de Kruif J; Peiris JS; Goudsmit J
    PLoS Med; 2006 Jul; 3(7):e237. PubMed ID: 16796401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS.
    Wang YD; Sin WY; Xu GB; Yang HH; Wong TY; Pang XW; He XY; Zhang HG; Ng JN; Cheng CS; Yu J; Meng L; Yang RF; Lai ST; Guo ZH; Xie Y; Chen WF
    J Virol; 2004 Jun; 78(11):5612-8. PubMed ID: 15140958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential patterns of cross-reactive antibody response against SARS-CoV-2 spike protein detected for chronically ill and healthy COVID-19 naïve individuals.
    Jaago M; Rähni A; Pupina N; Pihlak A; Sadam H; Tuvikene J; Avarlaid A; Planken A; Planken M; Haring L; Vasar E; Baćević M; Lambert F; Kalso E; Pussinen P; Tienari PJ; Vaheri A; Lindholm D; Timmusk T; Ghaemmaghami AM; Palm K
    Sci Rep; 2022 Oct; 12(1):16817. PubMed ID: 36207326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses
    Vishwakarma P; Yadav N; Rizvi ZA; Khan NA; Chiranjivi AK; Mani S; Bansal M; Dwivedi P; Shrivastava T; Kumar R; Awasthi A; Ahmed S; Samal S
    Front Immunol; 2021; 12():613045. PubMed ID: 33841395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins.
    Nunez-Castilla J; Stebliankin V; Baral P; Balbin CA; Sobhan M; Cickovski T; Mondal AM; Narasimhan G; Chapagain P; Mathee K; Siltberg-Liberles J
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.